Education
About Us
Working with TipRanks
Follow Us
Cardiex Limited (CDEXF)
OTHER OTC:CDEXF
CDEXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.36 - $0.36
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
$13.79M
Enterprise Value$25.99M
Total Cash (Recent Filing)$4.98M
Total Debt (Recent Filing)$4.44M
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.88
Enterprise Value/Revenue4.54
Enterprise Value/Gross Profit5.32
Enterprise Value/Ebitda-2.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CardieX Limited News
CDEXF FAQ
What was Cardiex Limited’s price range in the past 12 months?
Cardiex Limited lowest stock price was $0.36 and its highest was $0.36 in the past 12 months.
What is Cardiex Limited’s market cap?
Cardiex Limited’s market cap is $13.79M.
When is Cardiex Limited’s upcoming earnings report date?
Cardiex Limited’s upcoming earnings report date is Aug 28, 2025 which is in 19 days.
How were Cardiex Limited’s earnings last quarter?
Currently, no data Available
Is Cardiex Limited overvalued?
According to Wall Street analysts Cardiex Limited’s price is currently Overvalued.
Does Cardiex Limited pay dividends?
Cardiex Limited does not currently pay dividends.
What is Cardiex Limited’s EPS estimate?
Cardiex Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cardiex Limited have?
Currently, no data Available
What happened to Cardiex Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cardiex Limited?
Currently, no hedge funds are holding shares in CDEXF
CardieX Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
CDEXF Sentiment 93%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-467.81%
Trailing 12-Months
Asset Growth
-8.61%
Trailing 12-Months
Company Description
Cardiex Limited
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company undertakes contracts with pharmaceutical companies for the use of SphygmoCor XCEL devices; provides lab and data management services for clinical trials comprising end-to-end service that delivers clean datasets to study sponsors. It also develops home vascular health solutions, remote patient monitoring, decentralized clinical trials and solutions wearables, and medical health apps under the CONNEQT name, as well as CONNEQT Pulse device, a home-based heart health vital signs monitoring system, that measures central blood pressure, arterial waveforms, and various other proprietary arterial health parameters through its SphygmoCor technology. The company serves hospitals, clinics, research institutions and pharmaceutical companies. It has strategic collaboration agreement with LifeQ, Inc for wearable devices. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
CardieX Limited (CDEXF) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Cochlear
―
CSL
―
Vitasora Health
―
Nanosonics Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―